Clinical Research

AI-powered FFR-CT software linked to considerable cost savings, accurate predictions
According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.
Copper-based PSMA radiotracer shines in clinical trial
The tracer's extended half-life of over three hours could make it a promising candidate for future prostate cancer diagnostics.
Is IVL safe for patients with diabetes?
New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.
M-TEER still beneficial for high-risk patients with smaller mitral valve areas
Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.
Researchers receive $3.2M in federal funding to test new heart pump for children
The device, currently just a prototype, could be the first of its kind to gain FDA approval.

Ramon Varcoe explains the LIFE-BTK trial for the Abbott Esprit fully bioresobable scaffold at TCT23.

Fully bioresorbable stents boost care for CLI patients in LIFE-BTK trial

Ramon Varcoe, MBBS, co-principal investigator for the LIFE-BTK trial, discussed the results with Cardiovascular Business at TCT 2023. "I can't wait to start using these in my patients. It's going to make a huge difference."

Rasha Al-Lamee, MBBS, PhD, a cardiologist with the National Heart and Lung Institute in London

PCI benefits patients with stable chest pain, late-breaking data confirm

“Going forward, patients and medical teams have a choice of two pathways for chest pain relief: chest pain medication or PCI," one cardiologist said.

ChatGPT large language models radiology health care

AI generates concise, accurate radiology reports that rival humans’

While its sentences varied in length, GPT-4 produced shorter radiology reports without missing the facts.

Firas Zahr, MD,director of interventional cardiology, co-director, complex heart valve program, Oregon Health and Science University, discusses the one-year outcomes for transferral transcatheter mitral valve replacement (TMVR) in the Medtronic Intrepid Early Feasibility Study presented at TCT 2023.

Intrepid transfemoral transcatheter mitral valve shows favorable results after 1 year

Firas Zahr, MD, spoke to Cardiovascular Business about early data on the Medtronic TMVR device. His team's study is designed to follow patients for a total of five years.

PHOTO GALLERY: Interventional cardiology technologies at TCT 2023

Browse through some of the many highlights from TCT 2023 in San Francisco.

Matthias Götberg discusses iFR vs. FFR from the National SWEDEHEART Quality Registry at #TCT2023. #iFR

iFR and FFR are equal, new long-term analysis confirms

There were some concerns among researchers after one study suggested iFR may increase the risk of mortality. New data presented at TCT 2023, however, showed that the two technologies are linked to similar outcomes.

breast radiologist breast cancer mammography

Ultrasound combined with MRI is better able to identify cancerous lesions in breast tissue

Research out of China found that the pairing proved to be more accurate in identifying cancer in nonmass-like lesions.

Patients struggling with addiction, mental health are less likely to be screened for breast cancer

Researchers have shed light on the relationship between breast cancer screening and sociodemographic factors.

Clinical Research

AI-powered FFR-CT software linked to considerable cost savings, accurate predictions

Copper-based PSMA radiotracer shines in clinical trial

Is IVL safe for patients with diabetes?

M-TEER still beneficial for high-risk patients with smaller mitral valve areas

Researchers receive $3.2M in federal funding to test new heart pump for children